News

Merck, known as MSD outside the United States and Canada, announced that the U.S. Food and Drug Administration (FDA) has approved an additional recommended dosage of 400 mg every six…
Read More...

Q2Earth, Inc. announced that its wholly-owned subsidiary, QSAM Therapeutics Inc. has signed a Patent and Technology License Agreement and Trademark Assignment with IGL Pharma, Inc.…
Read More...

Pneumagen Ltd, a University of St Andrews spinout, focused on treating infectious disease and oncology by targeting the human glycome, today announced results from three separate in…
Read More...

Kamada Ltd. and Kedrion Biopharma, two prominent bio-pharmaceutical companies specialized in plasma-derived protein therapeutics, announced a global collaboration for the development,…
Read More...

In response to the novel coronavirus (SARS-CoV-2), Shionogi & Co., Ltd. (hereafter “Shionogi”), a pharmaceutical company with a major focus on infectious diseases, has joined the…
Read More...

Sutro Biopharma, Inc. announced updated interim data regarding safety and anti-tumor activity results in heavily pre-treated patients with ovarian cancer from its on-going Phase 1…
Read More...

Santhera Pharmaceuticals has entered into a collaboration agreement with Cold Spring Harbor Laboratory (CSHL) to investigate the potential of lonodelestat (POL6014), a potent inhibitor…
Read More...

CEPI, the Coalition for Epidemic Preparedness Innovations, today announced a ninth worldwide collaboration to develop a COVID-19 vaccine. CEPI will invest an initial US$3.5 million in a…
Read More...

Takeda Pharmaceutical Company Limited announced that the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy Designation for its investigational drug mobocertinib…
Read More...

Merck, known as MSD outside the United States and Canada, and the Institute for Systems Biology (ISB), announced a new research collaboration to investigate and define the molecular…
Read More...

Applied BioMath (www.appliedbiomath.com), the industry-leader in applying systems pharmacology and mechanistic modeling, simulation, and analysis to de-risk drug research and…
Read More...

JCR Pharmaceuticals Co., Ltd. announced that it has completed the previously announced acquisition of ArmaGen, Inc., a privately held US biopharmaceutical company headquartered in San…
Read More...

Takeda Pharmaceutical Company Limited announced that it has entered into an agreement to divest a portfolio of select non-core over-the-counter (OTC) and prescription pharmaceutical…
Read More...

Affinivax, Inc. a clinical stage biotechnology company with its novel MAPS technology platform for vaccines and immunotherapies, announced the completion of a $120 million Series B…
Read More...

Scancell Holdings plc, the developer of novel immunotherapies for the treatment of cancer, announces that it has initiated a research programme to develop a vaccine for COVID-19. The…
Read More...

ProThera Biologics, Inc. and Takeda Pharmaceutical Company Limited announced that they have entered into a global licensing agreement to develop a novel plasma-derived Inter-alpha…
Read More...

Catalent announced the completion of its $14 million expansion to increase the biologics packaging capabilities and capacity at its Bloomington, Indiana facility. The completed…
Read More...

Griffith University researchers have joined forces with scientists from Indian Immunologicals Limited (IIL), a leading vaccines manufacturing company based in Hyderabad, India to…
Read More...

Diamond Pharma Services announced its pharmacovigilance division, Diamond PV Services, has acquired PharmaCentral (https://pharmacentral.ie/), an innovative pharmacovigilance services…
Read More...

Data from the Phase III REACH2 study published today in The New England Journal of Medicine show Jakavi (ruxolitinib) improves outcomes across a range of efficacy measures in patients…
Read More...